A recent study that validated a TDP-43 immunoassay for detecting C-terminal fragments of TDP-43 reported increased TDP-43 C-terminal fragments in human plasma from ALS patients [23]. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.